#sabc19 - Twitter Hashtag

Maryam Lustberg MD, MPH, FASCO

@maryam_lustberg

almost 6 years ago

@itsnot_pink @SABCSSanAntonio @chawnte3 #grasp19 #sabc19 #bcsm💔

1

7

1

0

Maryam Lustberg MD, MPH, FASCO

@maryam_lustberg

over 6 years ago

Thank you @debsetu @faceofstage4 @4RiseUp and @TPollastro for a wonderful @GRASPtweets session #ASCO20 #bcsm and a shout out to my first GRASP group @sisters_R_us @MarlenaDM and @chawnte3 in #SABC19

Debbie Denardi @debsetu

over 6 years ago

Just finished a #GRASPcancer session w @maryam_lustberg as our scientist. Thank u for sharing ur knowledge! Fantastic moderator @TPollastro. Great advocates @faceofstage4 & Marina Ivanovska. @itsnot_pink & @christeeny513, u make a difference everyday. Thank you! #ASCO20 #bcsm

debsetu's tweet photo. Just finished a #GRASPcancer session w @maryam_lustberg as our scientist. Thank u for sharing ur knowledge! Fantastic moderator @TPollastro. Great advocates @faceofstage4 & Marina Ivanovska. @itsnot_pink & @christeeny513, u make a difference everyday. Thank you! #ASCO20 #bcsm https://t.co/gB69BYo93d

0

8

2

0

1

7

3

0

Maryam Lustberg MD, MPH, FASCO

@maryam_lustberg

over 6 years ago

Standing ovation for @ChefGeib for her talk on #advocacy #bcsm #mbc @SABCSSanAntonio #sabc19

0

27

4

0

Maryam Lustberg MD, MPH, FASCO

@maryam_lustberg

over 6 years ago

#bcsm #SABC19 @OSUCCC_James @StoverLab

Dr.Clara Park, MD, FACS @KClaraPark

over 6 years ago

@StoverLab gives excellent updates on the role of genomic markers and immunotherapy in breast cancer @OSUCCC_James #bcsm

KClaraPark's tweet photo. @StoverLab gives excellent updates on the role of genomic markers and immunotherapy in breast cancer @OSUCCC_James #bcsm https://t.co/bDpcNRNmy5

1

6

1

0

9

0

Maryam Lustberg MD, MPH, FASCO

@maryam_lustberg

over 6 years ago

And closing remarks by @ChefGeib ! Excited to have @OSUCCC_James advocacy group joining us on Feb 1, 2020. If you are close by, I hope you join us for a wonderful #sabc19 @SABCSSanAntonio review #bcsm

The James at Ohio State @OSUCCC_James

over 6 years ago

Doctors Tari King from @DanaFarber and William J. Gradishar from @NorthwesternU will join OSUCCC – James experts in Columbus on 2/1 to share insights and info presented during the 2019 San Antonio #BreastCancer Symposium. Click for details/registration.

OSUCCC_James's tweet photo. Doctors Tari King from @DanaFarber and William J. Gradishar from @NorthwesternU will join OSUCCC – James experts in Columbus on 2/1 to share insights and info presented during the 2019 San Antonio #BreastCancer Symposium. Click for details/registration.

0

16

9

0

13

3

0

Medscape Oncology

@MedscapeOnc

over 6 years ago

Two separate phase 3 neoadjuvant trials in which immunotherapy was added to chemo for patients with early, TNBC but 2 vastly different outcomes. Why? And what’s next? https://t.co/SPD2DZ3lJw #SABC19 #bcsm

MedscapeOnc's tweet photo. Two separate phase 3 neoadjuvant trials in which immunotherapy was added to chemo for patients with early, TNBC but 2 vastly different outcomes. Why? And what’s next? https://t.co/SPD2DZ3lJw #SABC19 #bcsm https://t.co/VWaAYCS2uk

0

1

0

Medscape Oncology

@MedscapeOnc

over 6 years ago

The “most exciting study" presented at #SABC19 suggests a new standard is likely for some metastatic HER2 breast cancer. #bcsm https://t.co/9kaGT37N7O

0

4

5

0

forthebreastofus @thebreastofus

over 6 years ago

Thank you @IBCResearch! 😘Meeting you was certainly one of my favorite parts of #sabc19. Sending you love and light 💓💓💓 - @BraveBeauty26

IBC Research Fdn @IBCResearch

over 6 years ago

Had the opportunity to meet this delightful woman at #SABCS19 and learned firsthand what how amazing she truly is!! Big hugs @thebreastofus #bcsm

0

9

1

0

1

7

0

Naoto T Ueno, MD, PhD

@teamoncology

over 6 years ago

Our phase II data of Radium223 plus endocrine therapy in bone dominant metastasis. We have shown that Radium can control bone metastasis. One of the few drugs that are a bone-specific treatment for breast cancer. More development needed. #bcsm #sabc19 https://t.co/4iwdMjgftr

0

34

14

0

Medscape

@Medscape

over 6 years ago

In a first of its kind result, an investigational oral form of paclitaxel yielded a higher overall response rate than the IV form of the chemotherapy drug among women with metastatic breast cancer. https://t.co/Yo7XnmtFAJ #SABC19

0

7

3

0

Medscape Pharmacists @MedscapePharm

over 6 years ago

The “most exciting study presented” at #SABC19 suggests a new standard is likely for some metastatic HER2 #breastcancer. #bcsm https://t.co/xPGVOiBZqJ

0

2

0

Medscape Oncology

@MedscapeOnc

over 6 years ago

Two separate phase 3 neoadjuvant trials in which immunotherapy was added to chemo for patients with early, TNBC but 2 vastly different outcomes. Why? And what’s next? https://t.co/f3MnGCITKT #SABC19 #bcsm

1

10

4

0

Medscape

@Medscape

over 6 years ago

Two separate phase 3 neoadjuvant trials, in which immunotherapy was added to chemo for patients with early TNBC, but two vastly different outcomes. Why? And what’s next? https://t.co/xpGnsPTWM4 #SABC19 #bcsm

0

3

0

Mustafa Özdoğan, MD

@ozdogan_md

over 6 years ago

Tüm meme radyoterapisine karşı, hızlandırılmış kısmi radyoterapinin 10 yıllık sonuçları https://t.co/q5QKX5zTjQ #kanser #onkoloji #SABC19 #memekanseri

0

7

0

IBC Network Foundation Australia @IBC_Australia

over 6 years ago

Proud of my mentor, and perpetual leader of IBC studies @InflammatoryBCa whom chaired a translational research session, hosted an alumni dinner and was active amongst the poster sessions at #sabc19 🙏 @cbartholomeusz1 @rhalvarez1 @Bmp4TW

IBC_Australia's tweet photo. Proud of my mentor, and perpetual leader of IBC studies @InflammatoryBCa whom chaired a translational research session, hosted an alumni dinner and was active amongst the poster sessions at #sabc19 🙏 @cbartholomeusz1 @rhalvarez1 @Bmp4TW https://t.co/3IGxirEEmW

0

6

1

0

Medscape Oncology

@MedscapeOnc

over 6 years ago

In a first of its kind result, an investigational oral form of paclitaxel yielded a higher overall response rate than the IV form of the chemotherapy drug among women with metastatic breast cancer. https://t.co/oGoSLeI98e #SABC19 #bcsm

2

11

1

0

Medscape Oncology

@MedscapeOnc

over 6 years ago

The “most exciting study" presented at #SABC19 suggests a new standard is likely for some metastatic HER2 breast cancer. #bcsm https://t.co/ZE1DRejN5V

0

6

1

0

Freddy Pizart @fpizart

over 6 years ago

Medscape: The “most exciting study presented” at #SABC19 suggests a new standard is likely for some metastatic HER2 breast cancer. #bcsm https://t.co/dlWBerU3LD https://t.co/AEhrxLxSAQ

Medscape

@Medscape

over 6 years ago

The “most exciting study presented” at #SABC19 suggests a new standard is likely for some metastatic HER2 breast cancer. #bcsm https://t.co/F9vHp6lM6Q

0

15

4

1

0

2

1

0

IBC Network Foundation Australia @IBC_Australia

over 6 years ago

#sabc19 always well entertains the poster sessions. Work from Belgium is investigating how specific immune cells may be associated with IBC phenotype and progression.

IBC_Australia's tweet photo. #sabc19 always well entertains the poster sessions. Work from Belgium is investigating how specific immune cells may be associated with IBC phenotype and progression. https://t.co/wQvURSmjnh

0

3

1

0

Medscape

@Medscape

over 6 years ago

The “most exciting study presented” at #SABC19 suggests a new standard is likely for some metastatic HER2 breast cancer. #bcsm https://t.co/F9vHp6lM6Q

0

15

4

1

0

Top Tweets for #sabc19

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users